Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B

BACKGROUND/AIMS: Despite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore the potential efficacy of combination therapy consisting of pegylated interferon (p-IFN)...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Gut Liver
Hoofdauteurs: Wi, Chung-Il, Kim, W. Ray, Gross, John B., Stadheim, Linda M., Poterucha, John J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Editorial Office of Gut and Liver 2016
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933423/
https://ncbi.nlm.nih.gov/pubmed/26190580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl14256
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items